A dull week comes to an end, with the EUR/USD pair closing it little changed in the 1.1870 price zone as speculative interest is trapped between coronavirus outbreaks and vaccine hopes. Economic growth figures will gather attention in the next few days. Meanwhile, bulls remain in control of the world’s most popular currency, but can’t break above 1.1900, FXStreet’s Chief Analyst Valeria Bednarik briefs.
“Several front-runners´ vaccine producers reported encouraging progress in their coronavirus shots, according to early results from stage three trials. Yet, at the same time, the world is reporting over 600K new cases per day. As the week went by, more US states and cities announced restrictive measures to curb the spread, although to no avail. Strict lockdown measures in Europe seem to help a bit, but the situation in the Old Continent is far from optimal. Market participants are worried, as a steep economic downturn became clear in this the last quarter of the year.”
“Next Monday, Markit will release the preliminary November estimates of its PMIs. Manufacturing activity and services output are seen contracting from October levels in Europe, while US ones are seen stable.”
“Germany will publish next Tuesday is Q3 Gross Domestic Product, expected to be down by 10.1% in the three months to September, and the November IFO survey. The US will unveil later in the week October Durable Goods Orders. It will be a shortened week, as the US celebrates Thanksgiving on Thursday.”
“As it happened last week, the first resistance level is the 1.1910/20 price zone, followed by the year high at 1.2011, with a less relevant level around 1.1960. The low set in the previous week at 1.1745 provides support en route to the 1.1640/60 price zone.”
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.